Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

Hutchison China MediTech Begins Colorectal Cancer Trial

4th Apr 2014 09:25

LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its majority-owned research and development company Hutchison MediPharma Ltd has initiated a Phase II clinical trial in colorectal cancer patients in China for fruquintinib. Fruquintinib is the company's investigational small Read More

UK BROKER RATINGS: Jefferies Raises REIT Price Targets

1st Apr 2014 09:11

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />GOLDMAN RAISES INTL AIRLINES GROUP (IAG) PRICE TARGET TO 430 (420) PENCE - 'NEUTRAL' <br />----------<br />BARCLAYS CUTS PRUDEN Read More

DIRECTOR DEALINGS: AstraZeneca Non-Executive Director Buys Shares

26th Mar 2014 11:33

LONDON (Alliance News) - AstraZeneca PLC Wednesday said Non-Executive Director Geneviève Berger bought 460 shares at a price of 3,896 pence a share Tuesday. Following this transaction, Berger holds 1,790 shares. Shares in the biopharmaceutical company were trading at 3,903.00p, up 0.3 Read More

UK Dividends Calendar - Week Ahead

24th Mar 2014 06:42

Read More

UK Dividends Calendar - Week Ahead

21st Mar 2014 16:11

Read More

UK Dividends Calendar - Week Ahead

21st Mar 2014 06:13

Read More

UK Dividends Calendar - Week Ahead

20th Mar 2014 16:02

Read More

UK Dividends Calendar - Week Ahead

20th Mar 2014 06:33

Read More

UK Dividends Calendar - Week Ahead

19th Mar 2014 16:42

Read More

DIRECTOR DEALINGS: AstraZeneca Non-Executive Buys Shares

19th Mar 2014 15:10

LONDON (Alliance News) - AstraZeneca PLC Wednesday said non-executive Director Geneviève Berger bought 430 shares at a price of 3,955 pence a share Tuesday. Following this transaction, Berger holds 1,330 shares. Shares in the biopharmaceutical company were trading at 3,996.00p up 0.4% Read More

AstraZeneca Unveils Nexium Direct-to-Patient Program

19th Mar 2014 12:34

LONDON (Alliance News) - AstraZeneca said it launched Nexium Direct, a program that provides eligible patients the option of having brand-name Nexium delivered directly to their home. Nexium Direct is part of AstraZeneca Direct, a web-based offering that delivers select brand name prescription me Read More

UK Dividends Calendar - Week Ahead

19th Mar 2014 06:15

Read More

UK Dividends Calendar - Week Ahead

18th Mar 2014 15:54

Read More

UK Dividends Calendar - Week Ahead

18th Mar 2014 06:31

Read More

UK Dividends Calendar - Week Ahead

17th Mar 2014 15:51

Read More

UK BROKER RATINGS: Merill Lynch Cuts Tesco To Underperform

17th Mar 2014 10:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />BERENBERG CUTS SSE PRICE TARGET TO 1320 (1570) PENCE - 'HOLD' <br />----------<br />BERENBERG CUTS REED ELSEVIER TO 'HOLD' ('BUY Read More

TOP NEWS: Prudential And Standard Chartered Sign 15-Year Asia Deal

12th Mar 2014 11:29

LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Prudential</strong> PLC reported a sharp fall in 2013 pretax profits due to short-term fluctuations on investment returns, but its clo Read More

UK MORNING BRIEFING: Share Open Lower But Prudential Gains

12th Mar 2014 08:38

LONDON (Alliance News) - Share are lower at the open Wednesday, following Asian and US markets.<br /><br />Just after the open, insurer<strong> Prudential</strong> declared a 15% dividend increase for 2013. CEO Tidjane Thiam promised "more of the same, just better". It also announced an expand Read More

AstraZeneca To Write Down USD275M In Q1 As It Sells Alderley Park Site

12th Mar 2014 07:57

LONDON (Alliance News) - AstraZeneca PLC said Wednesday that it will book a USD275 million write down in the first quarter of 2013, as it announced the sale of its Alderley Park Site in Cheshire to Manchester Science Parks. The sale is part of AstraZeneca's plan to establish a new global re Read More

UK BROKER RATINGS: Barclays Raises Pharmaceutical Price Targets

10th Mar 2014 10:27

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning and Friday afternoon:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />DEUTSCHE BANK CUTS ROLLS-ROYCE PRICE TARGET TO 860 (1090) PENCE - 'SELL'<br />----------<br />MERRILL LYNCH Read More

FTSE 100 Latest
Value9,479.14
Change-12.11